Bionano Genomics Inc - ESG Rating & Company Profile powered by AI
This assessment of Bionano Genomics Inc uses data points from across the internet as well as from available filings by Bionano Genomics Inc. This ESG score covers seventeen UN SDGs including: 'Good Health & Wellbeing', 'Climate Action' and 'Life below Water'. This SDG assessment for Bionano Genomics Inc represents its reporting of the United Nations Sustainable Development Goals.
Bionano Genomics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.4; made up of an environmental score of 8.0, social score of 8.0 and governance score of 6.0.
7.4
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 256 | Sun Pharma Advanced Research Co Ltd | 7.5 | High |
| 256 | Prostatype Genomics AB | 7.5 | High |
| 288 | Bionano Genomics Inc | 7.4 | High |
| 288 | Bio Path Holdings Inc | 7.4 | High |
| 288 | Chugai Pharmaceutical Co Ltd | 7.4 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Bionano Genomics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Bionano Genomics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Bionano Genomics Inc report the average age of the workforce?
Sign up for free to unlockDoes Bionano Genomics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Bionano Genomics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Bionano Genomics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Bionano Genomics Inc offer flexible work?
Sign up for free to unlockDoes Bionano Genomics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Bionano Genomics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Bionano Genomics Inc conduct supply chain audits?
Sign up for free to unlockDoes Bionano Genomics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Bionano Genomics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Bionano Genomics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Bionano Genomics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Bionano Genomics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Bionano Genomics Inc disclose water use targets?
Sign up for free to unlockDoes Bionano Genomics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Bionano Genomics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Bionano Genomics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Bionano Genomics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Bionano Genomics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Bionano Genomics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Bionano Genomics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Bionano Genomics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Bionano Genomics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Bionano Genomics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Bionano Genomics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Bionano Genomics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Bionano Genomics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Bionano Genomics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Bionano Genomics Inc disclose its waste policy?
Sign up for free to unlockDoes Bionano Genomics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Bionano Genomics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Bionano Genomics Inc disclose energy use targets?
Sign up for free to unlockDoes Bionano Genomics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Bionano Genomics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Bionano Genomics Inc
These potential risks are based on the size, segment and geographies of the company.
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California.